Testosterone induces different-featured prostate hyperplasia in castrated and uncastrated mice.
- Author:
Wei-Gui SUN
1
;
Lan-Ping GAN
;
Guo-Qiang YU
;
Zhang-Qun YE
;
Zhen-Guo MI
;
Quan-Hong WANG
;
Cun-Zhi HAN
;
Lian-Sheng REN
;
Hong-Zhi WANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Hyperplasia; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Prostate; pathology; Prostatic Hyperplasia; drug therapy; pathology; Testosterone; therapeutic use
- From: National Journal of Andrology 2009;15(2):153-157
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the different features of hyperplasia in castrated and uncastrated mice after testosterone (T) treatment.
METHODSForty-eight BALB/c mice were randomly divided into 6 groups of 8 in each: castrated (A), uncastrated (B) , castrated + low T (C), uncastrated + low T (D), castrated + high T (E), uncastrated + high T (F). Groups C and D were treated with testosterone solution at the dose of 12.5 mg/(kg d) and Groups E and F at 125 mg/(kg d) for 20 consecutive days, while Groups A and B received saline only. All the mice were sacrificed on the 21st day, their ventral and dorsal prostate glands weighed and their pathological features studied.
RESULTSAtrophic prostates were observed in Group A, but normal in Group B; prostatic hyperplasia was found in both Group C and D, but more obvious in the latter (P <0.05); and a slightly higher degree of hyperplasia was noted in Groups E and F than in C and D. There was an increase in serum T and vascular endothelial growth factor (VEGF) concentration and a decrease in serum estrogen (E2) concentration in the testosterone treated groups.
CONCLUSIONBoth castrated and uncastrated mice develop prostate hyperplasia after short-term testosterone treatment, although in different degrees and with different features, which may help further the studies on the association of castration and androgen with prostate diseases.